Share Name Share Symbol Market Type Share ISIN Share Description
Medica Group Plc LSE:MGP London Ordinary Share GB00BYV24996 ORD 0.2P
  Price Change % Change Share Price Shares Traded Last Trade
  -7.00 -4.15% 161.50 91,442 15:20:05
Bid Price Offer Price High Price Low Price Open Price
160.00 162.00 168.00 160.00 168.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 36.81 2.07 1.21 133.5 198
Last Trade Time Trade Type Trade Size Trade Price Currency
15:20:05 AT 62 161.50 GBX

Medica (MGP) Latest News

More Medica News
Medica Investors    Medica Takeover Rumours

Medica (MGP) Discussions and Chat

Medica Forums and Chat

Date Time Title Posts
13/9/202109:29Medica Group769
04/8/200913:33Mercury Group: Charts and Comment254
24/7/200815:11Mercury Group...A New Beginning.668
14/10/200517:59Mercury Group (Old Cater Barnard) A New Beginning254
16/4/200407:53Make My Day5

Add a New Thread

Medica (MGP) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Medica trades in real-time

Medica (MGP) Top Chat Posts

Medica Daily Update: Medica Group Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker MGP. The last closing price for Medica was 168.50p.
Medica Group Plc has a 4 week average price of 153.50p and a 12 week average price of 145p.
The 1 year high share price is 185p while the 1 year low share price is currently 95p.
There are currently 122,428,836 shares in issue and the average daily traded volume is 62,330 shares. The market capitalisation of Medica Group Plc is £197,722,570.14.
melody9999: Liberum - We think Medica is navigating the COVID recovery well and is on-track to deliver the 14% revenue CAGR (fastest in the sector) that we forecast over the next 5 years. Remains our Top Pick with the next key catalyst due on September 7 – its CMD. Target price 235p
cheshire man: SABAH MEDDINGS | INSIDE THE CITY NHS work should be healthy for Medica Sabah Meddings Sunday July 25 2021, 12.01am, The Sunday Times As restrictions are relaxed, a key focus for hospitals will be the record lists of patients awaiting elective operations and scans. The most gloomy estimates suggest that these could take years to clear. This backlog is likely to boost demand for Medica Group’s services. The supplier of teleradiology, which allows radiologists to view images remotely, steps in when the NHS can’t keep up with demand, which is an increasing problem. Demand for radiologists in the UK is growing by between 5 and 6 per cent a year, but there is no spare capacity in the NHS. That’s where Medica comes in, offering teleradiology to hospitals that outsource about 20 per cent of their cases — a figure that has doubled over the past five years. It employs about 500 radiologists — often retired or who want to fit work around caring responsibilities. They read scans remotely, easing the pressure on busy hospitals. Medica began life in 2004 and floated on the London Stock Exchange in 2017 at 135p a share. Soon after, pricing pressure in the NHS nearly halved that value. But under new chief executive, Stuart Quin, Medica has invested in its software and recruited new radiologists. It has also teamed up with the artificial-intelligence firm Qure.ai to improve efficiency. In November, it expanded with the €16 million acquisition of Global Diagnostics Ireland, its counterpart there. And a recent joint venture with an Australian business, Integral Diagnostics, means Medica can use radiologists there when it’s night-time in the UK. All of this has put Medica’s share price on the road to recovery — it closed on Friday at 163p, valuing the business at £199.5 million. Revenues are expected to revive to £61.4 million this year, according to investment bank Liberum — up from £36.8 million in 2020. As hospitals have focused on Covid patients, demand for Medica’s services has been hit. Now, hospitals are addressing their backlog in elective activity — and that is likely to boost demand this year and next. In the UK, elective operations and scans have recovered to 75 per cent of pre-Covid levels. It should be busier during the summer as NHS radiologists go on holiday — meaning Medica can pick up the slack. Part of the shortage in radiologists is down to the ten years’ training required to be a consultant radiologist — of which there are currently about 4,000, although only 3,750 full-time as part-time working has increased. So there is a good chance Medica will be in demand in the months ahead. Buy.
fez77: Significant Director purchases showing strong confidence in future prospects. Have added even at this higher price.
mighunter: Liontrust had borrowed shares returned to them yesterday... Jupiter closing short? Judging by price, big buy of 887,800 shares just gone through the books. Liberum this morning reiterates Medica as joint top pick in Medical sector, alongside Puretech, with MGP buy and price target of 235p vs 220p previously. Hoping we can make good progress through gap above between 170-190p.
rivaldo: Good to see the share price continuing to (slowly!) climb - the bid price is now up to 159.5p - before tomorrow's results and (more importantly) outlook update
mighunter: Good overview of the company - Interview with Stuart Quin CEO. Also see on BBC that NHS operation waiting lists just hit 4.7m, highest since 2007. MGP sorely needed in future. HTtps://www.share-talk.com/stuart-quin-ceo-of-medica-group-plc-mgp-l-interview/
mighunter: Did anyone else notice/can give explanation to the near minute by minute buys today in MGP, at deal sizes averaging about 160 shares per trade? Near continual throughout the day, most unlike MGP normal trading pattern? Someone accumulating??
adamb1978: Helpful that the share price has run up nicely in the last few weeks given the placing to finance the acquisition!
discodave45: Hi Adam,Thanks for your views on MGP, have been looking at similar growth potential for this sector and had a cursory look at MGP. However I felt it was priced about right even for the anticipated recovery in FY21 (PE 15), for FY20 it's siting on a rating of 50 (if my eps calc of about 2.5p is correct).All the best though as who knows how MGP will do in the next few years but not for me on valuation, good luck.
velod: This post in response to The BigShortFella’s request to me on another forum and is in reply to BSFella. Have no position in this share, nor intention to take one, but now it’s been brought to my attention might put it on a watchlist somewhere, out of sheer Nosey-Parker-interest on my part. Hi BSFella, Had the impression you were a micro-cap guy so surprised this is a quarter billion-pound MCap company. As a trend follower, no I would not buy this, at this juncture, based solely on the share price action alone. Momentum is iffy; albeit with a recent bull trend initiated, but it’s yet to be established if THIS TIME it will hold and build. Can’t understand why as the company as distinct from the share price appears to be a right little belter. Have access to the Piotroski F-Score and (if anyone hasn’t heard of that just Google) was gobsmacked at how MGP, the business, scored. It only goes and achieves top marks! Not only top marks but flying colours too, kind of top Marks! The highest a company can achieve is 9 - and MGP is rated a right royal gold standard 9. You can’t get higher. And that tells me this is one well-run, mean machine business. That being the case, what the hell’s happened to the share price momentum? I’m not built for fundamentals, but things like Return On Capital and ROE are excellent – no wonder it scored so highly on the F-Score. The business per se, independent of the share price rating, is a stonking belter! So why am I not interested? The share price soared until mid-summer. What happened at the height of summer? Because since then the share price has been unimpressive. Why has the market withdrawn its admiration by turning its back on the SP? And why that big retrace today, Friday? Perhaps I should read the posts below; somebody must have an idea. Why has the market withdrawn its initial embrace? Is it the PE ratio? Does the market think the current PE ratio is unworthy and is holding back? It is above the market average but not that much, (Edit, Upon reflection, well - yes that much. It is a 'fair bit' above the average). Unless I trawled through analysts reports something about this share price level, irks the market. Trendlines: It is currently on a little bull rally, but it’s been on and off all summer like that and looks disappointing to me. I, personally don’t trust the share price so wouldn’t take a long position. nor a short position because the share price has no real momentum for either strategy to be reliable. Until a clear trend breaks AND holds it’s a sit it out on the side-lines job for me with this one. Great company. Rubbish share price momentum.
Medica share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210920 14:36:16